Navigation Links
HemoSonics Appoints Timothy Fischer President and Chief Executive Officer

CHARLOTTESVILLE, Va., Aug. 5, 2014 /PRNewswire/ -- HemoSonics, a medical diagnostic company developing a novel point-of-care instrument to measure coagulation, announced today that it has named Timothy J. Fischer as President and Chief Executive Officer. Fischer has been a pioneer in the in vitro diagnostics industry in the fields of hematology, oncology and pathology for the past 25 years. He has led the design, development and commercialization of dozens of novel diagnostic products. He holds over 40 patents and has authored numerous publications.

"We are pleased and fortunate to have Tim leading our Company as we turn the corner to commercialization," said William Moffitt, Chairman of the Board of Managers for HemoSonics. "His extensive knowledge of hemostasis and his experience in building high performing product development teams will enable us to fulfill our vision of delivering critical patient information at the point of care."

Prior to joining HemoSonics, Fischer served as Chief Operating Officer for LipoScience, a publicly traded in vitro diagnostics company. At LipoScience, he led the successful development of the Vantera® Clinical Analyzer from concept through development, regulatory approval and market adoption. Before joining LipoScience, he served as Vice President of Development for the Women's Health and Cancer business unit at Becton Dickinson (BD) and as the Vice President of Product Development for TriPath Oncology.

"HemoSonics' novel technology enables an unparalleled product that will save lives and reduce healthcare costs by providing comprehensive information in an easy to use format," said Fischer. "I am thrilled to be part of a team that will revolutionize hemostasis testing and directly impact patient care in the critical care setting."

Fischer holds a Bachelor of Science degree in Biology from Indiana University.

About HemoSonics, LLC

HemoSonics, LLC (, an in vitro diagnostics company, is developing and commercializing a novel ultrasound technology to address a significant unmet need in critical patient care.  Bleeding and clotting disorders are a major cause of morbidity and mortality, leading to complications, worse outcomes and longer hospital stays. HemoSonics is developing a platform and assays to identify coagulation dysfunctions in whole blood at the point-of-care in acute care settings, enabling physicians to improve quality of care while reducing overall healthcare costs.

HemoSonics' technology and products are currently labeled as Research Use Only and are not intended for clinical use at this time.

HemoSonics Contact:
Megan Shaw
(434) 260-0682

SOURCE HemoSonics, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
2. invendo medical Appoints Nachum (Homi) Shamir To The Companys Board Of Directors
3. Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
4. Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
5. ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development
6. Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
7. Pharmavite Appoints Timothy Toll Chief Customer Officer
8. Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer
9. BioDelivery Sciences Appoints Charles J. Bramlage and Dr. Barry I. Feinberg to its Board of Directors
10. PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board
11. Nonin Medical Appoints Ash Keswani Vice President of Marketing
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):